Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 96,004 | 82,772 | 78,056 | 71,278 | 73,165 |
| Operating Income | -96,004 | -82,772 | -78,056 | -71,278 | -73,165 |
| Interest Expense | 1,580 | 0 | 0 | 0 | 0 |
| Other Income | 11,808 | 8,740 | 8,731 | 6,318 | 7,141 |
| Pre-tax Income | -85,776 | -74,032 | -69,325 | -64,960 | -66,024 |
| Income Tax | 78 | 79 | 62 | 61 | 72 |
| Net Income Continuous | -85,854 | -74,111 | -69,387 | -65,021 | -66,096 |
| Net Income | $-85,854 | $-74,111 | $-69,387 | $-65,021 | $-66,096 |
| EPS Basic Total Ops | -1.14 | -1.06 | -1.03 | -1.11 | -1.13 |
| EPS Basic Continuous Ops | -1.14 | -1.06 | -1.03 | -1.11 | -1.13 |
| EPS Diluted Total Ops | -1.14 | -1.06 | -1.03 | -1.11 | -1.13 |
| EPS Diluted Continuous Ops | -1.14 | -1.06 | -1.03 | -1.11 | -1.13 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.06 | -1.03 | -1.11 | -1.13 |
| EBITDA(a) | $-97,336 | $-83,913 | $-79,392 | $-72,492 | $-74,526 |